For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged. These medications are proving to be highly effective for migraine ...

Migraines can be diagnosed by a healthcare provider using information from a medical history and physical exam. Migraines are recurrent episodes that usually manifest with headaches, and they can be ...

New drugs with improved efficacy and reduced side effects are needed for effective treatment and prevention of migraine. This article describes the pathophysiological mechanisms underlying ...

During this symposium, a panel of leading headache experts discussed the potential for an intravenous (IV) anti-CGRP therapy to advance current migraine management and elevate overall treatment ...

AbbVie has submitted its oral CGRP inhibitor atogepant for prevention of both episodic and chronic migraine ... acute migraine treatment in early 2020 and for prevention in May 2021.

Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular ...

may be the anatomical target of some of the current and emerging therapies to relieve migraine symptoms, and why this should prove to be a fruitful area for drug development for the treatment of ...

The new patches of hyperpigmentation may lighten after about eight weeks. Lightening creams are over-the-counter (OTC) treatments that work with select ingredients to help decrease pigmentation.

Drs Katy Munro and David Kernick continue on their mission to bust some myths and improve understanding of migraine. Come and hear them chat about exciting new treatment options, children with ...

NICE said Ajovy was an option for around 10,000 people in the UK in guidance issued in June, but Lilly says many more patients are eligible for its drug – around 144,000 people with episodic ...